Association between metformin use and risk of prostate cancer and its grade. - Wikidata - wikimedia - TriplyDB

Association between metformin use and risk of prostate cancer and its grade.

Association between metformin use and risk of prostate cancer and its grade.

http://www.wikidata.org/entity/Q43566439

about

Potential role for metformin in urologic oncology Metabolic syndrome and diabetes for the urologist Nutrition, dietary interventions and prostate cancer: the latest evidence Effect of metformin on cancer risk and treatment outcome of prostate cancer: a meta-analysis of epidemiological observational studies Metformin and longevity (METAL): a window of opportunity study investigating the biological effects of metformin in localised prostate cancer.Effect of metformin on progression of head and neck cancers, occurrence of second primary cancers, and cause-specific survival.Metformin therapy and prostate cancer risk: a meta-analysis of observational studies.Metformin use and risk of prostate cancer: results from the REDUCE study.Association between Metformin Use and Cancer Stage at Diagnosis among Elderly Medicare Beneficiaries with Preexisting Type 2 Diabetes Mellitus and Incident Prostate Cancer.Prospective study of Type 2 diabetes mellitus, anti-diabetic drugs and risk of prostate cancer.Diabetes and beta-adrenergic blockage are risk factors for metastatic prostate cancer.Statins and Metformin Use Is Associated with Lower PSA Levels in Prostate Cancer Patients Presenting for Radiation Therapy Targeting the 5'-AMP-activated protein kinase and related metabolic pathways for the treatment of prostate cancer.Bioactivity and prostate tissue distribution of metformin in a preprostatectomy prostate cancer cohort.Does Metformin Reduce Cancer Risks? Methodologic Considerations.AMPed up to treat prostate cancer: novel AMPK activators emerge for cancer therapy.Obesity, diabetes and aggressive prostate cancer hormone-naïve at initial diagnosis.Metformin and cancer in type 2 diabetes: a systematic review and comprehensive bias evaluation.A spatiotemporal hypothesis for the regulation, role, and targeting of AMPK in prostate cancer.Antidiabetic drug use and prostate cancer risk in the Finnish Randomized Study of Screening for Prostate Cancer.Metformin and prostate cancer mortality: a meta-analysis.Metformin: a review of its potential indications.Metformin: A Bridge between Diabetes and Prostate Cancer.Influence of metformin use on PSA values, free-to-total PSA, prostate cancer incidence and grade and overall survival in a prospective screening trial (ERSPC Aarau).A pilot 'window of opportunity' neoadjuvant study of metformin in localised prostate cancer.Impact of metabolic disorders on prostate cancer growth: Androgen and insulin resistance perspectives.Drugs for metabolic conditions and prostate cancer death in men on GnRH agonists.Metformin and the risk of prostate cancer across racial/ethnic groups: a population-based cohort study.Metformin, Asian ethnicity and risk of prostate cancer in type 2 diabetes: a systematic review and meta-analysis.A systematic review of the literature exploring the interplay between prostate cancer and type two diabetes mellitus.Association between metformin therapy and incidence, recurrence and mortality of prostate cancer: evidence from a meta-analysis.Mitochondrial Complex I Inhibitors Expose a Vulnerability for Selective Killing of Pten-Null Cells.

P2860

Q26747759-B3197D2A-2E3B-42DA-8936-3A577A7885DA Q26830106-9D80C3AF-3A28-445F-8CFC-C03F504AD126 Q28084566-3A72DB88-675C-44C1-99A6-D818D88F7F24 Q28542914-BBD0E8AE-8BAA-4198-950B-D9330EB979B7 Q33921635-B883F913-25D1-41CB-A580-82F24E19D0E8 Q35586709-8EE5925D-90C2-41D9-B0D3-B44D33BFC32F Q36182935-9273E578-67D9-4AED-9D4A-FF059D734B6B Q36296255-C902CB3A-BD44-4026-9B52-D68AF9E90078 Q37172118-0BB1A1B6-3FFD-4143-B1BF-F74C1FA6853C Q37561605-42956F46-8F77-4754-8A2A-ABDC8614C408 Q37658406-C9D5A12C-1744-4ABD-BEA6-0F457DAF4C66 Q37664965-C1FBA1D4-A0B8-42DF-8523-6F96A3AF03E4 Q38323902-B224F059-CD20-4882-926C-2B51E14F3D9D Q38660247-B1F24AB6-65E1-47F4-A1DC-480DE732C3D4 Q38687543-5926AFA2-2AFA-4A5A-9DF6-56EEA7060344 Q38833054-2C306111-B535-4834-AA83-47CAE9D0DA37 Q38838157-A1407BA3-97B5-4667-90E9-03651FFB171F Q38999875-1B76BFC9-B313-4B8F-A6DF-B9A6E4837A68 Q39124486-9B1E32E2-76E8-479C-A69A-E6690FB444A7 Q40382361-C08DF7D2-2251-48AD-8306-A4E33042CAE9 Q41149937-444C28B1-F88A-4CB3-9F8B-8676B98519FB Q41545473-5F023E9B-2F98-415C-A02F-CB83218C8619 Q42700292-69356A5E-04A4-4391-987C-F097245ADDEF Q44441338-98BB2C9C-85EE-4450-B903-71591098A97A Q46694127-AFFD41C6-D1B3-44F6-B3BA-BB358AF6F246 Q47129584-5B8D7222-C21B-439E-A50B-834D8AF6D551 Q47936579-C32CEF45-78E9-452F-B876-1672E4ABB9D0 Q48015989-D21163C0-6427-4E9D-8E72-D69FB9F4EE8D Q48268841-C0581295-4D0E-4CBB-8C9E-E1ADE116E879 Q49884540-E8C57388-D5BF-4D86-ABDF-3AC7AC312A86 Q53166209-2F64A400-FE34-407B-B4BE-57655915B606 Q55294637-2FA7B57F-4DA0-4B30-8F86-44496EF563AB

P2860

Association between metformin use and risk of prostate cancer and its grade.

http://www.wikidata.org/entity/Q43566439

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

Association between metformin use and risk of prostate cancer and its grade.

@en

Association between metformin use and risk of prostate cancer and its grade.

@nl

type

label

Association between metformin use and risk of prostate cancer and its grade.

@en

Association between metformin use and risk of prostate cancer and its grade.

@nl

prefLabel

Association between metformin use and risk of prostate cancer and its grade.

@en

Association between metformin use and risk of prostate cancer and its grade.

@nl

P1433

Q43566439-4D521514-3C00-48B3-84ED-9DD19653FB9A

P1476

Q43566439-A0C41156-CB30-4B58-B42F-B7EFE6443F9E

P2093

Q43566439-02513671-42DA-45D1-8E68-EB3DE840265D

Q43566439-3E48E80C-C562-46F4-A83B-D770BF543DA7

Q43566439-6A4429F1-AF6A-4A20-AA45-6DCEBB782F77

Q43566439-9DEC0E6E-3924-4861-A068-598F7644A527

Q43566439-A2DBA4E5-A4E9-4E7D-8C3F-506120890E12

P2860

Q43566439-0FDEC10F-A310-42FC-AFA6-89D61131B588

Q43566439-19C71566-22ED-41DF-8833-99F2A9DB00A0

Q43566439-22E763AA-AE1C-4F05-8006-A55CF42EC16E

Q43566439-275A0F8E-C558-4B42-B229-2849D220918C

Q43566439-2DFE1E9D-25C7-4041-B550-E28DBDD55801

Q43566439-32B6A9E2-552A-4C69-B1C0-C3E387A65744

Q43566439-44A842CD-2A8F-4C86-BC58-F0EA73AF0F6D

Q43566439-45908FA2-FCA4-43A9-BCF7-8F83130C9434

Q43566439-4E357A8A-7EAB-4792-B0C1-0179889AB280

Q43566439-54A791DF-21A3-4DE4-90E2-1BE36BDA33C1

P304

Q43566439-9A4503AD-C6CB-4104-831A-96D669E78124

P31

Q43566439-4383D83B-70CB-4F8E-94A7-2D1DACA88E03

P356

Q43566439-D2ED3D56-FDD1-47FC-B389-7B7B34685D2F

P407

Q43566439-3246011A-0586-49F3-A226-81E72E3B6CF1

P433

Q43566439-91250409-8F4E-4727-9086-6B03C5502E86

P478

Q43566439-9AF4637D-E938-4BF2-B30B-2288DE4750D1

P50

Q43566439-72742AF3-14B5-4274-A935-723BEDCA6CCE

Q43566439-C0031A22-58EE-4FB1-8C48-BE2533A27E29

P577

Q43566439-E5F01957-1998-497D-B365-CBC19AEDAB98

P5875

Q43566439-E08DBBBD-6137-44D9-935D-BDA51A75522D

P698

Q43566439-EE36A2BE-3766-4FF4-9A42-D60749DB74D6

P921

Q43566439-CBBFA25E-6C01-407D-ACC8-89A55462E983

P356

P1433

Journal of the National Cancer Institute

P1476

Association between metformin use and risk of prostate cancer and its grade.

@en

P2093

David Margel

http://www.w3.org/2001/XMLSchema#string

David Urbach

http://www.w3.org/2001/XMLSchema#string

Girish Kulkarni

http://www.w3.org/2001/XMLSchema#string

Lorraine L Lipscombe

http://www.w3.org/2001/XMLSchema#string

Neil Fleshner

http://www.w3.org/2001/XMLSchema#string

P2860

Role of AMP-activated protein kinase in mechanism of metformin action

Predictors of glycemic control among patients with Type 2 diabetes: a longitudinal study

Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths

AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism

Self-eating and self-killing: crosstalk between autophagy and apoptosis

Effect of dutasteride on the risk of prostate cancer.

Diabetes in Ontario: determination of prevalence and incidence using a validated administrative data algorithm.

Crosstalk between insulin/insulin-like growth factor-1 receptors and G protein-coupled receptor signaling systems: a novel target for the antidiabetic drug metformin in pancreatic cancer

Metformin and other biguanides in oncology: advancing the research agenda.

Latent carcinoma of prostate at autopsy in seven areas. The International Agency for Research on Cancer, Lyons, France.

P304

1123-1131

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/JNCI/DJT170

http://www.w3.org/2001/XMLSchema#string

P407

P433

15

http://www.w3.org/2001/XMLSchema#string

P478

105

http://www.w3.org/2001/XMLSchema#string

P50

Peter C. Austin

P577

2013-07-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

249321510

http://www.w3.org/2001/XMLSchema#string

P698

23853056

http://www.w3.org/2001/XMLSchema#string

P921